Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q1 EPS of ($0.58), $0.06 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $444 thousand versus the consensus estimate of $710 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.